These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39210426)

  • 1. Retraction Note: HOXD9 promotes epithelial-mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma.
    Lv X; Li L; Lv L; Qu X; Jin S; Li K; Deng X; Cheng L; He H; Dong L
    J Exp Clin Cancer Res; 2024 Aug; 43(1):246. PubMed ID: 39210426
    [No Abstract]   [Full Text] [Related]  

  • 2. HOXD9 promotes epithelial-mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma.
    Lv X; Li L; Lv L; Qu X; Jin S; Li K; Deng X; Cheng L; He H; Dong L
    J Exp Clin Cancer Res; 2015 Oct; 34():133. PubMed ID: 26514226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long non-coding RNA lncRNA-PE promotes invasion and epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-200a/b-ZEB1 pathway.
    Shen Y; Liu S; Yuan H; Ying X; Fu H; Zheng X
    Tumour Biol; 2017 May; 39(5):1010428317705756. PubMed ID: 28488544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway.
    Li SP; Xu HX; Yu Y; He JD; Wang Z; Xu YJ; Wang CY; Zhang HM; Zhang RX; Zhang JJ; Yao Z; Shen ZY
    Oncotarget; 2016 Jul; 7(27):42431-42446. PubMed ID: 27285757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXD9 promote epithelial-mesenchymal transition and metastasis in colorectal carcinoma.
    Liu M; Xiao Y; Tang W; Li J; Hong L; Dai W; Zhang W; Peng Y; Wu X; Wang J; Chen Y; Bai Y; Lin J; Yang Q; Wang Y; Lin Z; Liu S; Xiong J; Wang J; Xiang L
    Cancer Med; 2020 Jun; 9(11):3932-3943. PubMed ID: 32281284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
    Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
    Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma.
    Liang J; Yao N; Deng B; Li J; Jiang Y; Liu T; Hu Y; Cao M; Hong J
    J Cell Physiol; 2024 May; 239(5):e31237. PubMed ID: 38468464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.
    Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M
    Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-431 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the ZEB1-mediated epithelial-mensenchymal transition.
    Sun K; Zeng T; Huang D; Liu Z; Huang S; Liu J; Qu Z
    FEBS Open Bio; 2015; 5():900-7. PubMed ID: 26697292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma.
    Zhong Y; Yu F; Yang L; Wang Y; Liu L; Jia C; Cai H; Yang J; Sheng S; Lv Z; Weng L; Wu B; Zhang X
    J Transl Med; 2023 Nov; 21(1):817. PubMed ID: 37974228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction Note: Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma.
    Lei X; Liang Y; Chen J; Xiao S; Lei J; Li J; Duanmu J; Jiang Q; Liu D; Tang C; Li T
    Sci Rep; 2018 Aug; 8(1):11857. PubMed ID: 30072770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction Note: The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2.
    Li C; Lu L; Feng B; Zhang K; Han S; Hou D; Chen L; Chu X; Wang R
    Sci Rep; 2023 Mar; 13(1):5140. PubMed ID: 36991028
    [No Abstract]   [Full Text] [Related]  

  • 14. ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance.
    Zhang P; Sun Y; Ma L
    Cell Cycle; 2015; 14(4):481-7. PubMed ID: 25607528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor DCAF15 inhibits epithelial-mesenchymal transition by targeting ZEB1 for proteasomal degradation in hepatocellular carcinoma.
    Dong X; Han Y; Zhang E; Wang Y; Zhang P; Wang C; Zhong L; Li Q
    Aging (Albany NY); 2021 Apr; 13(7):10603-10618. PubMed ID: 33833131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph node metastasis of cervical cancer via the epithelial-mesenchymal transition pathway.
    Chen Z; Li S; Huang K; Zhang Q; Wang J; Li X; Hu T; Wang S; Yang R; Jia Y; Sun H; Tang F; Zhou H; Shen J; Ma D; Wang S
    Hum Pathol; 2013 Oct; 44(10):2097-105. PubMed ID: 23791009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transition.
    Luo W; Zhu X; Liu W; Ren Y; Bei C; Qin L; Miao X; Tang F; Tang G; Tan S
    Oncotarget; 2016 Dec; 7(52):86420-86432. PubMed ID: 27861158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma.
    Li T; Xie J; Shen C; Cheng D; Shi Y; Wu Z; Deng X; Chen H; Shen B; Peng C; Li H; Zhan Q; Zhu Z
    Oncogene; 2016 Mar; 35(12):1575-84. PubMed ID: 26073087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
    Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-186 regulates epithelial-mesenchymal transformation to promote nasopharyngeal carcinoma metastasis by targeting ZEB1.
    Tang L; Xiang Y; Zhou J; Li T; Jia T; Du G
    Braz J Otorhinolaryngol; 2024; 90(1):101358. PubMed ID: 37989078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.